wsf-1-in-1

WSF1-IN-1 (compound 136) is an orally active inhibitor of WSF1, intended for the study of WSF1-related tumors in patients with Wolfram syndrome (WS). In HepG2 parental and HepG2 WFS1 KO cell lines, WSF1-IN-1 has demonstrated IC50 values of 0.33 μM and >27 μM, respectively.